Michael Birrer
Impact in
-
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
-
- Cell death mechanisms and regulation 2
- Signaling Pathways in Disease 1
- Renal and related cancers 1
- RNA Interference and Gene Delivery 1
- Oncology 5
- Cancer-related Molecular Pathways 2
- Co-authors
- Melissa P. Johnston (1 shared paper)Timothy J. Bos (1 shared paper)Barbara A. Murphy (1 shared paper)Yaffa Rubinstein (1 shared paper)Alfred C. Johnson (1 shared paper)Gila Neta (1 shared paper)Charles Vinson (1 shared paper)Eileen D. Adamson (1 shared paper)
- Journals
- Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Genome biology (1 paper)International Journal of Cancer (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- United StatesTürkiyeCanada
In The Last Decade
Michael Birrer
8 papers receiving 157 citations
Peers
Comparison fields: 5 of 51
- Oncology 65
- Cancer Research 26
- Immunology and Allergy 9
- Molecular Biology 101
- Cell Biology 18
Countries citing papers authored by Michael Birrer
This map shows the geographic impact of Michael Birrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Birrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Birrer more than expected).
Fields of papers citing papers by Michael Birrer
This network shows the impact of papers produced by Michael Birrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Birrer. The network helps show where Michael Birrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Birrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 62 | |
| 2 | 2000 | 41 | |
| 3 | 2008 | 38 | |
| 4 | 2024 | 8 | |
| 5 | 2007 | 7 | |
| 6 | 2004 | 1 | |
| 7 | PHASE 3 TRIAL OF AVELUMAB (ANTI-PD-L1) IN COMBINATION WITH AND/OR FOLLOWING PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH UNTREATED OVARIAN CANCER | 2016 | 1 |
| 8 | 2017 | 1 | |
| 9 | Abstract #LB-244: Six biomarker panel detects early stage ovarian cancer | 2009 | 0 |
About Michael Birrer
Michael Birrer is a scholar working on Molecular Biology, Oncology, Reproductive Medicine, Pathology and Forensic Medicine and Genetics, having authored 9 papers that have together received 159 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Cancer-related Molecular Pathways (2 papers), Cell death mechanisms and regulation (2 papers), Signaling Pathways in Disease (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Renal and related cancers (1 paper), Cancer Mechanisms and Therapy (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Oncology (65 citations), Cancer Research (26 citations), Immunology and Allergy (9 citations), Molecular Biology (101 citations) and Cell Biology (18 citations). Michael Birrer has collaborated with scholars based in United States, Türkiye and Canada. Frequent co-authors include Melissa P. Johnston, Timothy J. Bos, Barbara A. Murphy, Yaffa Rubinstein, Alfred C. Johnson, Gila Neta, Charles Vinson, Eileen D. Adamson, Zhenyu Jia and Dan Mercola. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Genome biology, International Journal of Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.